823809-16-1 Usage
Uses
Used in Pharmaceutical Industry:
1H-IMIDAZO[4,5-C]QUINOLINE-1-PROPANAMINE,4-AMINO-2-(ETHOXYMETHYL) is used as a potential therapeutic agent for the development of drugs targeting various medical conditions. Its unique structure and properties contribute to its potential efficacy in treating specific diseases.
Used in Antiviral Treatments:
In the field of antiviral research, 1H-IMIDAZO[4,5-C]QUINOLINE-1-PROPANAMINE,4-AMINO-2-(ETHOXYMETHYL) may be utilized as a component in the development of antiviral drugs. Its specific properties could potentially help in inhibiting viral replication or reducing the severity of viral infections.
Used in Antitumor Treatments:
1H-IMIDAZO[4,5-C]QUINOLINE-1-PROPANAMINE,4-AMINO-2-(ETHOXYMETHYL) may also be studied for its potential in antitumor treatments. Its unique structure could play a role in targeting cancer cells or enhancing the effectiveness of existing cancer therapies.
Used in Medicinal Chemistry and Drug Design Research:
Furthermore, 1H-IMIDAZO[4,5-C]QUINOLINE-1-PROPANAMINE,4-AMINO-2-(ETHOXYMETHYL) may be employed in medicinal chemistry and drug design research. Its properties and interactions with biological systems can provide valuable insights for the development of new drugs and therapeutic strategies.
Check Digit Verification of cas no
The CAS Registry Mumber 823809-16-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,2,3,8,0 and 9 respectively; the second part has 2 digits, 1 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 823809-16:
(8*8)+(7*2)+(6*3)+(5*8)+(4*0)+(3*9)+(2*1)+(1*6)=171
171 % 10 = 1
So 823809-16-1 is a valid CAS Registry Number.
823809-16-1Relevant articles and documents
CONJUGATED TLR7 AND/OR TLR8 AND TLR2 AGONISTS
-
Page/Page column, (2015/07/22)
A conjugated compound of formula Q-Z—R4 wherein Q is a TLR7 and/or TLR8 agonist and Z—R4 is a TLR2 agonist, and the uses thereof in the treatment of infection, cancer or immune disorders or for use in vaccines.
Novel compositions of TLR7 and/or TLR8 agonists conjugated to lipids
-
Paragraph 0250, (2014/01/08)
The present invention concerns a conjugated compound of formula Q-Z-R4 wherein Q is a TLR7 and/or TLR8 agonist and Z-R4 is a lipid covalently linked to an amino acid or peptide coupled to a polyamine group, and a process for the manufacture of said conjugated compound, as well as a complex formed between said conjugated compound and a polyanionic molecule and a pharmaceutical composition containing said conjugated compound or complex. The invention further concerns the use of said conjugated compound or complex in the treatment of infection, cancer or immune disorders or for use in vaccines.
Novel Compounds
-
, (2011/06/24)
The present invention provides compounds of formula (I): wherein Ra, Rb, Rc, R1, R2, R3, X1, Y1, Z1, A, n and m are as defined in the specification, and pharmaceutically acceptable salts thereof, as well as processes for their preparation, pharmaceutical compositions containing them and their use in therapy.
IMIDAZOQUINOLINES WITH IMMUNO-MODULATING PROPERTIES
-
Page/Page column 56, (2009/01/20)
The present invention provides compounds of formula (I) wherein Ra, R1, R2, R3, X1, Y1, Z1, A, n and m are as defined in the specification, and pharmaceutically acceptable salts
